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BACKGROUND: Mucormycosis is one of the rapidly progressing and 
lethal form of fungal infection which involves the nose and paranasal 
sinuses of the head and the neck regions. Mucormycosis also remains a 
threat to patients with uncontrolled diabetes or other predisposing 
systemic conditions. It manifests as rhinocerebral, pulmonary, 
gastrointestinal, cutaneous or disseminated form. The underlying 
conditions can influence clinical presentation and often delay diagnosis, 
with resultant poor outcomes.  
CASE DETAILS: We report a case of rhinocerebral mucormycosis in a 
75 year-old diabetic patient with emphasise on diagnosis, treatment and 
survival options of patient from this potentially fatal fungal infection. 
Extra oral examination revealed mild non-tender swelling on the face, 
unable to see from left eye, impaired sense of smell, difficulty in speech 
and nasal stuffiness. Intra-oral examination showed necrosis of mucosa 
and underlying bone in relation to canine to the tuberosity area of the left 
vestibular region of the maxilla. 
CONCLUSION: Timely diagnosis is critical to survival and minimization 
of morbidity.  Institution of surgical and medical therapy is critical in 
maximizing the likelihood of good outcome. 
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INTRODUCTION   
 
Mucormycosis refers to several different diseases caused by infection 
with fungi in the order of Mucorales. Rhizopus species are the most 
common causative organisms (1,2). Saprophytic aerobic fungi of the 
class Phycomycetes (order Mucorales) cause rhinocerebral 
mucormycosis, also known as phycomycosis. Phycomycetes are 
ubiquitous in nature commonly found in decaying vegetation, soil 
and bread mold. They grow rapidly and can release large numbers of 
airborne spores. Thus, they are frequently found colonizing the oral 
mucosa, the nose, the paranasal sinuses and the throat (3). Most 
mucormycosis infections are life-threatening, and risk factors, such 
as diabetic ketoacidosis and neutropenia are present in most cases 
which can lead to complications (4). In diabetic patients, especially 
with elevated blood sugar levels, the spores germinate, hyphae 
develop and fungi begin an inexorable march through lung tissues, 
invading blood vessels and surrounding tissues. As blood vessels 
become involved, thrombosis occurs resulting in tissue necrosis and 
fungi continue to grow in this devitalised tissue (5). Rhinocerebral 
mucormycosis (ROCM) is the most common form of mucormycosis 
in patients with diabetes mellitus. The infection develops after 
inhalation of fungal sporangio spores into the paranasal sinuses. 
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Rhinocerebral mucormycosis most commonly 
presents in an acute setting mimicking symptoms 
of sinusitis or periorbital cellulitis. The pleiotropic 
clinical manifestations and elusive presentation of 
mucormycosis often delay diagnosis, with 
resultant poor outcomes. A high index of 
suspicion for mucormycosis based on appropriate 
risk stratification and improved laboratory 
diagnosis are important for improving the natural 
history of this devastating infection (5). In the case 
presented here, the subtler lesion progressed 
rapidly leading to tissue necrosis and spread to the 




A   75 year-old male edentulous patient reported 
with complaint of problem in denture wearing and 
swelling on the face. The patient is edentulous and 
wearing denture from the past 10 years. The 
patient is unable to wear denture from the past two 
months because of some changes in supporting 
alveolar bone. According to the patient, some 
discoloration appeared in the left maxillary region 
on the buccal side of the ridge (~ 4 months ago) 
followed by necrosis of underlying bone within 
two months. There was no pain and no abnormal 
sensation. The patient was a known diabetic since 
few years, under medication for the same. He also 
complained of nasal congestion and headache.   
He got his right eye operated on for cataract 6 
before months and kept on post-operative 
medication and scheduled to be operated on for 
the left eye cataract after few days. However, the 
patient got ulceration in the oral cavity before the 
operation. He took medication for the same after 
which he got swelling over the face, on the left 
part of the face along with protrusion of left eye 
and impaired visibility. The patient got some tests 
done; namely, CT scan of the Head and the Orbit, 
and he was diagnosed with the left orbital cellulitis 
and the left paranasal sinusitis. He got treatment 
for the same.  He reported back to his eye surgeon 
and started taking medication, but unfortunately, 
he got cornea of left eye damaged. 
Extra oral examination revealed mild non- 
tender swelling on the face, unable to see from the 
left eye, impaired sense of smell, difficulty in 
speech and nasal stuffiness (Figure 1). Intra-oral 
examination showed necrosis of mucosa and 
underlying bone in relation to canine to tuberosity 
area of the left vestibular region of maxilla (Figure 
2). There was an abnormal communication 
between vestibule and palate under it due to bone 
loss in the same region. 
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Figure 1: Extra-oral photograph showing swelling over the left part of the face and protrusion of left eye 
and impaired visibility. 
 
 
Figure 2: Intra- oral photograph showing necrosis of mucosa and underlying bone in relation to canine to 
tuberosity area of left vestibular region of maxilla along with abnormal communication b/w vestibule and 
palate. 
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A CT Scan showed a homogeneous density mass 
involving the greater palatine and the 
sphenopalatine foramen obliterating the two 
(Figure 3). The nasal turbinates were bilaterally 
obliterated. Hard palate osteolysis was seen more 
on the left side. Radiographic interpretation was 
suggestive of Rhinocerebral mucoromycosis. 
A biopsy was advised. Hard tissue specimen 
along with the adjacent soft tissue was excised 
under local anesthesia and was sent for 
histopathological examination. Histopathological 
examination with hematoxylin and eosin stain, 
identified presence of broad non-septae with 
branching at right angle along with areas of 
necrosis (Figure 4).The patient was advised for 
medication and surgical debridement of the 
involved area along with administration of 
antifungal therapy such as   liposomal 
Amphotericin-B 5mg\kg\day intravenously for 10 




Figure 3: CT scan showing a homogenous density 
mass involving maxillary sinus and nasal 
turbinates bilaterally obliterated. 
 
Figure 4:  Photomicrograph showing presence of 
non-septae hyphae branching at right angle along 





Mucormycosis is a serious, relatively uncommon 
invasive fungal infection and one of the most 
aggressive and lethal invasive mycoses (5).
 
The 
predisposing factors for mucormycosis are 
uncontrolled diabetes (particularly in patients 
having ketoacidosis), malignancies such as 
lymphomas and leukemias, renal failure, organ 
transplant, immunosuppressive therapy, cirrhosis, 
and AIDS (6).
 
Mucorales species are vasotropic, 
causing tissue infarctions, and the mucormycosis 
spectrum ranges from cutaneous, rhinocerebral, 
and sinopulmonary to disseminated and frequently 
fatal infections, especially in immune-
compromised hosts (7).
 
Reports have suggested 
that the ability of serum of immuno-compromised 
patients to inhibit Rhizopus invitro is reduced, 
which makes them suitable hosts to opportunistic 
fungal infections (8). In diabetic patients, 
especially with elevated blood sugar levels, the 
spores germinate, hypae develop, fungi begin an 
inexorable march through the tissues as blood 
vessels become involved, thrombosis occurs, 
resulting in tissue necrosis and fungi continue to 
grow in this devitalised tissue causing further 
damage to surrounding tissues (9). The presence 
of chronic diabetes in our patient too led to 
necrosis of palate. Rhinocerebral mucormycosis 
(ROCM) is the most common form of 
mucormycosis in patients with diabetes mellitus. 
The infection develops after inhalation of fungal 
sporangiospores into the paranasal sinuses. Upon 
germination, the invading fungus may spread 
inferiorly to invade the palate, posteriorly to 
invade the sphenoid sinus, laterally into the 
cavernous sinus to involve the orbits or cranially 
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to invade the brain which can prove fatal (10). Our 
patient had uncontrolled diabetes which is a well-
known predisposing factor for mucormycosis 
along with spread of lesion from the palate into 
adjacent tissues. The initial symptoms of ROCM 
are consistent with those of sinusitis and 
periorbital cellulitis and include eye and/or facial 
pain and facial numbness followed by blurry 
vision (5,10). Signs and symptoms that suggest 
mucormycosis in susceptible individuals include, 
unilateral periorbital facial pain, facial cellulitis, 
orbital inflammation, eyelid edema, proptosis, 
acute ocular motility changes, nasal discharge, 
nasal stuffiness headacheand acute vision loss (5). 
If blood supply to eye is affected by invasion of 
retinal artery, blindness develops. A black necrotic 
eschar is the hallmark of mucormycosis (12,13).  
Among the differential diagnosis, 
rhinocerebral mucormycosis may initially 
resemble bacterial sinusitis and may mimic 
malignancy. Rhinocerebral mucormycosis may be 
confused with allergic fungal sinusitis, which is 
caused by phaeohyphomycoses in individuals with 
histories of allergic rhinitis, elevated 
immunoglobulin E levels, nasal polyps and 
recurrent or chronic sinusitis. Allergic fungal 
sinusitis slowly progresses over months to years, 
although it causes proptosis and a large 
rhinocerebral mass, it does not invade tissue or 
meninges. Aspergillosis can cause a similar 
disease, with CNS invasion, and carries a poor 
prognosis. An important difference is that 
itraconazole may play a role in treatment. 
Histologic staining can differentiate between the 
fungi (14). The pleiotropic clinical manifestations 
with other lesions were ruled out with 
radiographic and histopathology report. A 
definitive diagnosis of mucormycosis can be made 
by tissue biopsy that identifies the characteristic 
hyphae. In order to differentiate 
histopathologically from other types of lesions 
such as aspergillosis, which shows presence of 
narrow, septae hypae with narrow angle branching 
was done. In this case, the fungus was identified 
by hematoxylin and eosin stain. 
  Treatments of mucormycosis need to be fast 
and aggressive because by the time even the 
presumptive diagnosis is made, often the patient 
has suffered significant tissue damage that cannot 
be reversed. Most patients require both surgical 
and medical treatments. The line of treatment for 
such cases requires aggressive surgical 
debridement of the infected area; otherwise, the 
patient is likely to die. Medications also plays an 
important role. Two main goals are sought at the 
same time: antifungal medications to slow or halt 
fungal spread and medications to treat any 
debilitating underlying diseases. Amphotericin B 
(initially intravenous) is the usual drug of choice 
for antifungal treatment. Patients with underlying 
diseases like diabetes need their diabetes optimally 
controlled. Patients may need additional surgeries 
and usually need antifungal therapy for an 
extended time period (weeks to months) 
depending on the severity of the disease (15).
 
The 
prognosis of mucormycosis is usually fair to poor; 
the prognosis depends on the overall health of the 
patient, the speed of diagnosis and treatment, the 
patient's ability to respond to treatments and the 
complete debridement of the infected body area. 
In this patient, the line of treatment advised was 
aggressive surgical debridement of the infected 
area along with administration of amphotericin B 
as it is the drug of choice in treatment of 
mucormycotic infection (2,6,11). The patient was 
under observation for his ability to respond to 
treatment due to old age and overall health of 
patient. 
  Mucormycosis is a serious, relatively 
uncommon invasive fungal infection. Early 
diagnosis is essential because by the time even the 
presumptive diagnosis is made, often the patient 
has suffered significant tissue damage that cannot 
be reversed. The pleiotropic clinical 
manifestations and elusive presentation of 
mucormycosis often delay diagnosis, with 
resultant poor outcomes. Timely diagnosis is 
critical to survival and minimization of morbidity. 
Institution of surgical and medical therapy is 
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